AI-generated summary
The authors report a preliminary prospective study of antimicrobial photodynamic therapy as an adjunct for angular cheilitis in 13 critically ill patients in an intensive care unit in Brazil. Using methylene blue followed by 660 nm low-level laser, they reported complete lesion regression in 40% of patients at 72 hours and a clinical cure rate of 61.5% at final follow-up, with no adverse effects reported. The study was small, lacked a control group, and had a 30.8% loss to follow-up.
- Participants
- 13
- Who or what was studied
- Critically ill patients admitted to the intensive care unit of an infectious disease referral hospital in Northeastern Brazil, predominantly with HIV infection and diabetes mellitus, with angular cheilitis
- Wavelengths
- 660 nm
- Limits stated in the abstract
- Preliminary study with a small sample, no control group, and a 30.8% loss to follow-up in the intensive care setting.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
This preliminary prospective study aimed to evaluate the effectiveness of antimicrobial photodynamic therapy (aPDT) as an adjunct treatment for angular cheilitis (AC) in critically ill patients and to investigate its feasibility in a high-complexity hospital setting. The study included 13 patients admitted to the intensive care unit (ICU) of a referral infectious disease hospital in Northeastern Brazil. The aPDT protocol consisted of 0.1% methylene blue (10-minute pre-irradiation) followed by low-level laser therapy (660 nm, 4 J/point, 40 s) applied to three points per affected commissure. Clinical evolution was monitored at T1 (72 h), T2 (7 days), and T3 (follow-up), with lesions classified according to severity. Most patients presented severe systemic compromise, predominantly related to HIV infection and diabetes mellitus. In addition, 76.9% of patients exhibited concomitant oral candidiasis, and 92.3% were receiving systemic antifungal therapy. Complete lesion regression was observed in 40% of patients within 72 h (T1). By the final follow-up (T3), the overall clinical cure rate reached 61.5% (8/13), including cases of delayed resolution confirmed up to day 15. Although a 30.8% loss to follow-up occurred due to the inherent challenges of the intensive care setting, no adverse effects or complications were reported. Within the limitations of this preliminary study, aPDT demonstrated promising clinical applicability as an adjunctive approach for managing angular cheilitis in critically ill patients.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.